Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Mahler, Michael ^a   Meroni, Pier Luigi ^b   Bossuyt, Xavier ^c   Fritzler, Marvin J ^d  

^a INOVA DIAGNOSTICS INC   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SCREENING; AUTOIMMUNE DISEASE; AUTOMATED PATTERN RECOGNITION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEP 2 CELL LINE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; MEDICAL TERMINOLOGY; MULTIPLEX BEAD BASED ASSAY; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID PHASE ASSAY; STAINING; STANDARDIZATION; AUTOIMMUNE DISEASES; BLOOD; CELL LINE; DEVICES; DIAGNOSTIC ERROR; FLUORESCENT ANTIBODY TECHNIQUE; FORECASTING; IMMUNOLOGY; LABORATORY AUTOMATION; PREVENTION AND CONTROL; STANDARDS; TRENDS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOMATION, LABORATORY; CELL LINE; DIAGNOSTIC ERRORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORECASTING; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 84901019272     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/315179     Document Type: Review

References (161)

1. Coons A. H., Kaplan M. H., Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. The Journal of Experimental Medicine 1950 91 1 1 13 2-s2.0-76549253723
2. Friou G. J., Finch S. C., Detre K. D., Interaction of nuclei and globulin from lupus erythematosis serum demonstrated with fluorescent antibody. Journal of Immunology 1958 80 4 324 329 2-s2.0-70449204573
3. Friou G. J., Setting the scene: a historical and personal view of immunologic diseases, autoimmunity and ANA. Clinical and Experimental Rheumatology 1994 12 supplement 11 S23 S25 2-s2.0-0028582132
4. Hargraves M. M., Richmond H., Morton R., Presentation of two bone marrow elements, the tart cell and the L.E. cell. Proceedings of the Staff Meetings of the Mayo Clinic 1948 23 25 28
5. Holman H. R., Deicher H. R., Kunkel H. G., The L. E. cell and the L. E. serum factors. Bulletin of the New York Academy of Medicine 1959 35 7 409 418 2-s2.0-0001670311
6. Moore A. E., Sabachewsky L., Toolan H. W., Culture characteristics of four permanent lines of human cancer cells. Cancer Research 1955 15 598 602
7. Tan E. M., Antinuclear antibodies in diagnosis and management. Hospital Practice 1983 18 1 79 84 2-s2.0-0020530719 (Pubitemid 13118041)
8. Mahler M., Fritzler M. J., Epitope specificity and significance in systemic autoimmune diseases. Annals of the New York Academy of Sciences 2010 1183 267 287 2-s2.0-75749123045 10.1111/j.1749-6632.2009.05127.x
9. Fritzler M. J., Fritzler M. L., The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Current Medicinal Chemistry 2006 13 21 2503 2512 2-s2.0-33748556839 10.2174/092986706778201639 (Pubitemid 44364152)
10. Fritzler M. J., Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 2006 15 7 422 427 2-s2.0-33746625215 10.1191/0961203306lu2327oa (Pubitemid 44147087)
11. Wiik A. S., Gordon T. P., Kavanaugh A. F., Lahita R. G., Reeves W., Van Venrooij W. J., Wilson M. R., Fritzler M., Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care and Research 2004 51 2 291 298 2-s2.0-1842780166 (Pubitemid 38468717)
12. Meroni P. L., Schur P. H., ANA screening: an old test with new recommendations. Annals of the Rheumatic Diseases 2010 69 8 1420 1422 2-s2.0-77955462255 10.1136/ard.2009.127100
13. Wiik A. S., Høier-Madsen M., Forslid J., Charles P., Meyrowitsch J., Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. Journal of Autoimmunity 2010 35 3 276 290 2-s2.0-77957820978 10.1016/j.jaut.2010.06.019
14. Holman H., Robbins W., Antinuclear antibodies in systemic lupus erythematosus. Arthritis & Rheumatology 1959 2 468 471
15. Egerer K., Roggenbuck D., Hiemann R., Weyer M.-G., Büttner T., Radau B., Krause R., Lehmann B., Feist E., Burmester G.-R., Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Research and Therapy 2010 12 2, article R40 2-s2.0-77956478503 10.1186/ar2949
16. Kivity S., Gilburd B., Agmon-Levin N., Carrasco M. G., Tzafrir Y., Sofer Y., Mandel M., Buttner T., Roggenbuck D., Matucci-Cerinic M., Danko K., Hoyos M. L., Shoenfeld Y., A novel automated indirect immunofluorescence autoantibody evaluation. Clinical Rheumatology 2012 31 3 503 509 2-s2.0-84859785377 10.1007/s10067-011-1884-1
17. Melegari A., Bonaguri C., Russo A., Luisita B., Trenti T., Lippi G., A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmunity Reviews 2012 11 713 716
18. Arbuckle M. R., McClain M. T., Rubertone M. V., Hal Scofield R., Dennis G. J., James J. A., Harley J. B., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine 2003 349 16 1526 1533 2-s2.0-0142009533 10.1056/NEJMoa021933 (Pubitemid 37255038)
19. Eriksson C., Kokkonen H., Johansson M., Hallmans G., Wadell G., Rantapää-Dahlqvist S., Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Research and Therapy 2011 13 1, article R30 2-s2.0-79951800941 10.1186/ar3258
20. Kampfrath T., Levinson S. S., Brief critical review: statistical assessment of biomarker performance. Clinica Chimica Acta 2013 419 102 107
21. Agmon-Levin N., Damoiseaux J., Kallenberg C., International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Annals of Rheumatic Diseases 2014 73 17 23 10.1136/annrheumdis-2013-203863
22. Abeles A. M., Abeles M., The clinical utility of a positive antinuclear antibody test result. American Journal of Medicine 2013 126 342 348
23. Tan E. M., Feltkamp T. E. W., Smolen J. S., Butcher B., Dawkins R., Fritzler M. J., Gordon T., Hardin J. A., Kalden J. R., Lahita R. G., Maini R. N., McDougal J. S., Rothfield N. F., Smeenk R. J., Takasaki Y., Wiik A., Wilson M. R., Koziol J. A., Range of antinuclear antibodies in "healthy" individuals. Arthritis & Rheumatism 1997 40 9 1601 1611 2-s2.0-0030830193 10.1002/art.1780400909 (Pubitemid 27426153)
24. González D. A., León A. C. D., Varela A. R., García M. G., Rahola M. D. S., Pérez M. D. C. R., Hernández A. G., Falcón M. J. F., Díaz B. B., Autoantibody detection with indirect immunofluorescence on HEp-2 cells: starting serum dilutions for systemic rheumatic diseases. Immunology Letters 2011 140 1-2 30 35 2-s2.0-80051782470 10.1016/j.imlet.2011.06.001
25. Bossuyt X., Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmunity Reviews 2009 8 7 543 548 2-s2.0-67349253618 10.1016/j.autrev.2009.01.013
26. Vermeersch P., Bossuyt X., Comparative analysis of different approaches to report diagnostic accuracy. Archives of Internal Medicine 2010 170 8 734 735 2-s2.0-77951661525 10.1001/archinternmed.2010.84
27. Kavanaugh A. F., Solomon D. H., Schur P., Reveille J. D., Sherrer Y. R. S., Lahita R., Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Care and Research 2002 47 4 429 433 2-s2.0-0037103227 (Pubitemid 34856133)
28. Op De Beeck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., Bossuyt X., Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmunity Reviews 2011 10 12 801 808 2-s2.0-80053274380 10.1016/j.autrev.2011.06.005
29. Op De Beéck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., Bossuyt X., Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmunity Reviews 2012 12 137 143
30. Schouwers S., Bonnet M., Verschueren P., Westhovens R., Blockmans D., Marien G., Bossuyt X., Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clinical Chemistry and Laboratory Medicine 2014 52 4 547 551 10.1515/cclm-2013-0610
31. Bossuyt X., Fieuws S., Detection of antinuclear antibodies: added value of solid phase assay? Annals of the Rheumatic Diseases 2014 73, article e10 10.1136/annrheumdis-2013-204793
32. Vercammen M., Meirlaen P., Sennesael J., Velkeniers B., T'Kint S., Verbruggen L., Haentjens P., Broodtaerts L., Demanet C., De Waele M., Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Clinical Chemistry and Laboratory Medicine 2007 45 4 505 512 2-s2.0-34247358283 10.1515/CCLM.2007.096 (Pubitemid 46632217)
33. Wenzel J., Gerdsen R., Uerlich M., Bauer R., Bieber T., Boehm I., Antibodies targeting extractable nuclear antigens: historical development and current knowledge. British Journal of Dermatology 2001 145 6 859 867 2-s2.0-0035725496 10.1046/j.1365-2133.2001.04577.x (Pubitemid 34204458)
34. Damoiseaux J. G. M. C., Cohen Tervaert J. W., From ANA to ENA: how to proceed? Autoimmunity Reviews 2006 5 1 10 17 2-s2.0-28744449120 10.1016/j.autrev.2005.05.007 (Pubitemid 41759437)
35. Sherer Y., Gorstein A., Fritzler M. J., Shoenfeld Y., Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 2004 34 2 501 537 2-s2.0-14244250736 10.1016/j.semarthrit.2004.07.002 (Pubitemid 40288129)
36. Copple S. S., Sawitzke A. D., Wilson A. M., Tebo A. E., Hill H. R., Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies. American Journal of Clinical Pathology 2011 135 5 678 684 2-s2.0-79955016785 10.1309/AJCP6R8EELGODAYW
37. Shanmugam V. K., Swistowski D. R., Saddic N., Wang H., Steen V. D., Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis. Clinical Rheumatology 2011 30 10 1363 1368 2-s2.0-80755190036 10.1007/s10067-011-1766-6
38. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis & Rheumatism 1982 25 11 1271 1277 2-s2.0-0020436689 (Pubitemid 13221242)
39. Petri M., Orbai A. M., Alarcon G. S., Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatology 2012 64 2677 2686
40. Andreoli L., Pregnolato F., Burlingame R. W., Allegri F., Rizzini S., Fanelli V., Radice A., Corace C., Sinico R. A., Meroni P. L., Tincani A., Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? Journal of Autoimmunity 2008 30 1-2 51 57 2-s2.0-38049072128 10.1016/j.jaut.2007.11.004
41. Assassi S., Fritzler M. J., Arnett F. C., Norman G. L., Shah K. R., Gourh P., Manek N., Perry M., Ganesh D., Rahbar M. H., Mayes M. D., Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. Journal of Rheumatology 2009 36 10 2250 2256 2-s2.0-70450179804 10.3899/jrheum.090340
42. Zafrir Y., Gilburd B., Carrasco M. G., Kivity S., Sanchez-Castanon M., Lopez-Hoyos M., Mandel M., Szmyrka M., Shoenfeld Y., Agmon-Levin N., Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases. Immunologic Research 2013 56 451 456
43. Granito A., Muratori P., Quarneti C., Pappas G., Cicola R., Muratori L., Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Review of Molecular Diagnostics 2012 12 1 65 74 2-s2.0-82955247118 10.1586/erm.11.82
44. Muratori P., Granito A., Pappas G., Muratori L., Lenzi M., Bianchi F. B., Autoimmune liver disease 2007. Molecular Aspects of Medicine 2008 29 1-2 96 102 2-s2.0-40049085314 10.1016/j.mam.2007.09.009
45. Bogdanos D. P., Komorowski L., Disease-specific autoantibodies in primary biliary cirrhosis. Clinica Chimica Acta 2011 412 7-8 502 512 2-s2.0-79551490697 10.1016/j.cca.2010.12.019
46. Agmon-Levin N., Shapira Y., Selmi C., Barzilai O., Ram M., Szyper-Kravitz M., Sella S., Katz B.-S. P., Youinou P., Renaudineau Y., Larida B., Invernizzi P., Gershwin M. E., Shoenfeld Y., A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. Journal of Autoimmunity 2010 34 1 55 58 2-s2.0-75149135547 10.1016/j.jaut.2009.08.009
47. Savige J. A., Gallicchio M., Chang L., Parkin J. D., Autoantibodies in systemic vasculitis. Australian and New Zealand Journal of Medicine 1991 21 4 433 437 2-s2.0-0026210425
48. Beigel F., Schnitzler F., Paul Laubender R., Pfennig S., Weidinger M., Göke B., Seiderer J., Ochsenkühn T., Brand S., Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF- α antibody-treated patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2011 17 1 91 98 2-s2.0-78650162670 10.1002/ibd.21362
49. Mancho C., Sainz Á., García-Sancho M., Villaescusa A., Tesouro M. A., Rodríguez-Franco F., Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease. Journal of Veterinary Diagnostic Investigation 2010 22 4 553 558 2-s2.0-77954904045
50. Nielsen H., Wiik A., Elmgreen J., Granulocyte specific antinuclear antibodies in ulcerative colitis: Aid in differential diagnosis of inflammatory bowel disease. Acta Pathologica Microbiologica et Immunologica Scandinavica: C Immunology 1983 91 1 23 26 2-s2.0-0020533160 (Pubitemid 13119159)
51. Zauli D., Crespi C., Dall'Amore P., Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 1985 32 2 140 144 2-s2.0-0021810212 (Pubitemid 15046229)
52. Al-Shukaili A. K., Al-Jabri A. A., Al-Moundhari M. S., Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer. Saudi Medical Journal 2006 27 12 1873 1877 2-s2.0-39049185668 (Pubitemid 351850258)
53. Armas J. B., Dantas J., Mendonça D., Farto R., Ribeiro M., Herrero-Beaumont G., Gouveia J., McHugh N. J., Anticardiolipin and antinuclear antibodies in cancer patients-a case control study. Clinical and Experimental Rheumatology 2000 18 2 227 232 2-s2.0-0034042101 (Pubitemid 30208268)
54. Blaes F., Klotz M., Huwer H., Straub U., Kalweit G., Schimrigk K., Schäfers H.-J., Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Annals of Thoracic Surgery 2000 69 1 254 258 2-s2.0-0033981030 10.1016/S0003-4975(99)01198-4 (Pubitemid 30078859)
55. Daniels T., Zhang J., Gutierrez I., Elliot M. L., Yamada B., Heeb M. J., Sheets S. M., Wu X., Casiano C. A., Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 2005 62 1 14 26 2-s2.0-10144237224 10.1002/pros.20112 (Pubitemid 39614289)
56. Imai H., Nakano Y., Kiyosawa K., Tan E. M., Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 1993 71 26 35 (Pubitemid 23019277)
57. Imran A., Neelam F., Tariq M., Incidence of circulating antinuclear antibodies in cancer patients. Indian journal of medical sciences 2003 57 3 113 116 2-s2.0-0242271840
58. Borowoy A. M., Pope J. E., Silverman E., Fortin P. R., Pineau C., Smith C. D., Arbillaga H., Gladman D., Urowitz M., Zummer M., Hudson M., Tucker L., Peschken C., Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Seminars in Arthritis and Rheumatism 2012 42 179 185
59. Fernández A., Quintana G., Matteson E. L., Restrepo J. F., Rondón F., Sánchez Á., Iglesias A., Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clinical Rheumatology 2004 23 6 523 526 2-s2.0-9444280208 10.1007/s10067-004-0951-2 (Pubitemid 39562259)
60. Tani C., D'Aniello D., Delle S. A., Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmunity Reviews 2013 12 537 541
61. Nossent H., Rekvig O. P., Antinuclear antibody screening in this new millennium: farewell to the microscope? Scandinavian Journal of Rheumatology 2001 30 3 123 126 2-s2.0-0035000905 10.1080/030097401300162860 (Pubitemid 32476914)
62. Kavanaugh A., Tomar R., Reveille J., Solomon D. H., Homburger H. A., Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Archives of Pathology and Laboratory Medicine 2000 124 1 71 81 2-s2.0-0033979858 (Pubitemid 30053777)
63. Mahler M., Ngo J. T., Schulte-Pelkum J., Luettich T., Fritzler M. J., Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Research and Therapy 2008 10 6, article R131 2-s2.0-57049084479 10.1186/ar2548
64. Kang I., Siperstein R., Quan T., Breitenstein M. L., Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies. Clinical Rheumatology 2004 23 6 509 515 2-s2.0-9444247023 10.1007/s10067-004- 0937-0 (Pubitemid 39562257)
65. Bossuyt X., Luyckx A., Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clinical Chemistry 2005 51 12 2426 2427 2-s2.0-28044462897 10.1373/clinchem.2005.058552 (Pubitemid 41692609)
66. Hoffman I. E. A., Peene I., Veys E. M., De Keyser F., Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clinical Chemistry 2002 48 12 2171 2176 2-s2.0-0036892180 (Pubitemid 35397559)
67. Bossuyt X., Mariën G., Vanderschueren S., A 67-year-old woman with a systemic inflammatory syndrome and sicca. Clinical Chemistry 2010 56 9 1508 1509 2-s2.0-77956386034 10.1373/clinchem.2010.150789
68. Tri G. P., Wong R. C. W., Adelstein S., Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clinical and Diagnostic Laboratory Immunology 2002 9 1 1 7 2-s2.0-0036145903 10.1128/CDLI.9.1.1-7.2002 (Pubitemid 34084268)
69. Solomon D. H., Kavanaugh A. J., Schur P. H., Solomon D. H., Schur P., Kavanaugh A. F., Reveille J. D., Sherrer Y. R. S., Lahita R., Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Care and Research 2002 47 4 434 444 2-s2.0-0037103187 (Pubitemid 34856134)
70. Perner P., Perner H., Müller B., Mining knowledge for HEp-2 cell image classification. Artificial Intelligence in Medicine 2002 26 1-2 161 173 2-s2.0-0036754439 10.1016/S0933-3657(02)00057-X (Pubitemid 35291832)
71. Hiemann R., Büttner T., Krieger T., Roggenbuck D., Sack U., Conrad K., Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmunity Reviews 2009 9 1 17 22 2-s2.0-69649107067 10.1016/j.autrev.2009.02.033
72. Willitzki A., Hiemann R., Peters V., Sack U., Schierack P., Rodiger S., Anderer U., Conrad K., Bogdanos D. P., Reinhold D., Roggenbuck D., New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clinical and Developmental Immunology 2012 2012 8 10.1155/2012/284740 284740
73. Voigt J., Krause C., Rohwader E., Saschenbrecker S., Hahn M., Danckwardt M., Feirer C., Ens K., Fechner K., Barth E., Martinetz T., Stocker W., Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clinical and Developmental Immunology 2012 2012 7 10.1155/2012/651058 651058
74. Bertin D., Jourde-Chiche N., Bongrand P., Bardin N., Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence. Clinical and Developmental Immunology 2013 2013 8 10.1155/2013/182172 182172
75. Roggenbuck D., Hiemann R., Schierack P., Reinhold D., Conrad K., Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution. Clinical Chemistry and Laboratory Medicine 2013 1 3
76. Bonroy C., Verfaillie C., Smith V., Persijn L., De W. E., De K. F., Devreese K., Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clinical Chemistry and Laboratory Medicine 2013 51 1771 1779
77. Bossuyt X., Cooreman S., De B. H., Verschueren P., Westhovens R., Blockmans D., Marien G., Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clinica Chimica Acta 2013 415 101 106
78. Foggia P., Percannella G., Soda P., Vento M., Benchmarking HEp-2 cells classification methods. IEEE Transactions on Medical Imaging 2013 32 1878 1889
79. Roggenbuck D., Hiemann R., Bogdanos D., Reinhold D., Conrad K., Standardization of automated interpretation of immunofluorescence tests. Clinica Chimica Acta 2013 421 168 169
80. Kidd K., Cusi K., Mueller R., Goodner M., Boyes B., Hoy E., Detection and identification of significant ANAs in previously determined ANA negative samples. Clinical Laboratory 2005 51 9-10 517 521 2-s2.0-27844495168 (Pubitemid 41644191)
81. Bossuyt X., Frans J., Hendrickx A., Godefridis G., Westhovens R., Mariën G., Detection of anti-SSA antibodies by indirect immunofluorescence. Clinical Chemistry 2004 50 12 2361 2369 2-s2.0-9244253731 10.1373/clinchem. 2004.035964 (Pubitemid 39552173)
82. Watanabe A., Kodera M., Sugiura K., Usuda T., Tan E. M., Takasaki Y., Tomita Y., Muro Y., Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis & Rheumatism 2004 50 3 892 900 2-s2.0-1542283747 10.1002/art.20096 (Pubitemid 38326190)
83. Shovman O., Gilburd B., Barzilai O., Shinar E., Larida B., Zandman-Goddard G., Binder S. R., Shoenfeld Y., Evaluation of the BioPlex 2200 ANA screen. Analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Annals of the New York Academy of Sciences 2005 1050 380 388 2-s2.0-23744482616 10.1196/annals.1313.120 (Pubitemid 41129457)
84. Gniewek R. A., Stites D. P., McHugh T. M., Hilton J. F., Nakagawa M., Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clinical and Diagnostic Laboratory Immunology 1997 4 2 185 188 2-s2.0-0030895496 (Pubitemid 27130231)
85. Avaniss-Aghajani E., Berzon S., Sarkissian A., Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens. Clinical and Vaccine Immunology 2007 14 5 505 509 2-s2.0-34250335666 10.1128/CVI.00034-07
86. Sugisaki K., Takeda I., Kanno T., Nogai S., Abe K., Sakuma H., Kasukawa R., An anti-nuclear antibody-negative patient with systemic lupus erythematosus (SLE) accompanied with anti-ribosomal P antibody (anti-P). Internal Medicine 2002 41 11 1047 1051 2-s2.0-0036859914 (Pubitemid 35423099)
87. Muro Y., Sugiura K., Morita Y., Tomita Y., Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay. Scandinavian Journal of Rheumatology 2009 38 6 460 463 2-s2.0-70450189021 10.3109/03009740903008767
88. Peene I., Van Ael W., Vandenbossche M., Vervaet T., Veys E., De Keyser F., Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies. Clinical Rheumatology 2000 19 4 291 295 2-s2.0-0033856074 (Pubitemid 30612561)
89. Fritzler M. J., Hanson C., Miller J., Eystathioy T., Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate. Journal of Clinical Laboratory Analysis 2002 16 2 103 108 2-s2.0-0036216497 10.1002/jcla.10026 (Pubitemid 34293089)
90. Tanaka N., Muro Y., Sugiura K., Tomita Y., Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening. Modern Rheumatology 2008 18 6 585 592 2-s2.0-57649167461 10.1007/s10165-008-0100-x
91. Wang S. L., Wang F. F., Chen S. L., Shen N., Xue F., Ye P., Bao C. D., Gu Y. Y., Yu C. Z., Wilson A., Wallace D. J., Weisman M. H., Lu L. J., Expression localization and clinical application of exogenous Smith proteins D1 in gene transfected HEp-2 cells. International Journal of Rheumatic Diseases 2013 16 303 309
92. Dahle C., Skogh T., Åberg A. K., Jalal A., Olcén P., Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. Journal of Autoimmunity 2004 22 3 241 248 2-s2.0-1642399760 10.1016/j.jaut.2003.12.004 (Pubitemid 38369185)
93. Fritzler M. J., Rattner J. B., Luft L. M., Edworthy S. M., Casiano C. A., Peebles C., Mahler M., Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmunity Reviews 2011 10 4 194 200 2-s2.0-79951854792 10.1016/j.autrev.2010.09.025
94. Khan S., Alvi A., Holding S., Kemp M. L., Raine D., Doré P. C., Sewell W. A. C., The clinical significance of antinucleolar antibodies. Journal of Clinical Pathology 2008 61 3 283 286 2-s2.0-40449126067 10.1136/jcp.2007. 049692 (Pubitemid 351354230)
95. Bizzaro N., Tonutti E., Visentini D., Alessio M. G., Platzgummer S., Morozzi G., Antico A., Villalta D., Piller-Roner S., Vigevani E., Antibodies to the lens and cornea in anti-DFS70-positive subjects. Annals of the New York Academy of Sciences 2007 1107 174 183 2-s2.0-34648840849 10.1196/annals.1381.019 (Pubitemid 47528794)
96. Okamoto M., Ogawa Y., Watanabe A., Sugiura K., Shimomura Y., Aoki N., Nagasaka T., Tomita Y., Muro Y., Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. Journal of Autoimmunity 2004 23 3 257 266 2-s2.0-14244259323 10.1016/j.jaut.2004.07.004 (Pubitemid 40288107)
97. Kuwabara N., Itoh Y., Igarshi T., Fukunaga Y., Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies. Autoimmunity 2009 42 6 492 496 2-s2.0-70249089052 10.1080/08916930902736663
98. Muro Y., Sugiura K., Morita Y., Tomita Y., High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus 2008 17 3 171 176 2-s2.0-42549142948 10.1177/0961203307086311 (Pubitemid 351588938)
99. Ganapathy V., Casiano C. A., Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis & Rheumatism 2004 50 3 684 688 2-s2.0-1542373697 10.1002/art.20095 (Pubitemid 38326165)
100. Ganapathy V., Daniels T., Casiano C. A., LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmunity Reviews 2003 2 5 290 297 2-s2.0-0042763088 10.1016/S1568-9972(03)00063-6 (Pubitemid 37083497)
101. Mahler M., Hanly J. G., Fritzler M. J., Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmunity Reviews 2012 11 9 642 645 2-s2.0-83655202759 10.1016/j.autrev.2011.11.005
102. Mahler M., Fritzler M. J., The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clinical and Developmental Immunology 2012 2012 6 10.1155/2012/494356 494356
103. Mariz H. A., Sato E. I., Barbosa S. H., Rodrigues S. H., Dellavance A., Andrade L. E., Ana HEp-2 pattern is a critical parameter for discriminating ana-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis & Rheumatology. Arthritis Rheum. 2011;63:191-200
104. Fritzler M. J., The antinuclear antibody test: last or lasting gasp? Arthritis & Rheumatism 2011 63 1 19 22 2-s2.0-78650796222 10.1002/art.30078
105. Ogawa Y., Sugiura K., Watanabe A., Kunimatsu M., Mishima M., Tomita Y., Muro Y., Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. Journal of Autoimmunity 2004 23 3 221 231 2-s2.0-14244257153 10.1016/j.jaut.2004.07.003 (Pubitemid 40288104)
106. Fenger M., Wiik A., Høier-Madsen M., Lykkegaard J. J., Rozenfeld T., Hansen M. S., Samsoe B. D., Jacobsen S., Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clinical Chemistry 2004 50 11 2141 2147 2-s2.0-7044241196 10.1373/clinchem.2004.038422 (Pubitemid 39425853)
107. Tonutti E., Bassetti D., Piazza A., Visentini D., Poletto M., Bassetto F., Caciagli P., Villalta D., Tozzoli R., Bizzaro N., Diagnostic accuracy of Elisa methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 2004 37 2 171 176 2-s2.0-2342634473 10.1080/08916930310001657010 (Pubitemid 38594280)
108. Kern P., Kron M., Hiesche K., Measurement of antinuclear antibodies: assessment of different test systems. Clinical and Diagnostic Laboratory Immunology 2000 7 1 72 78 2-s2.0-0033956049 (Pubitemid 30051465)
109. López-Hoyos M., Rodríguez-Valverde V., Martinez-Taboada V., Performance of antinuclear antibody connective tissue disease screen. Annals of the New York Academy of Sciences 2007 1109 322 329 2-s2.0-34848813912 10.1196/annals.1398.038 (Pubitemid 47511375)
110. Sinclair D., Saas M., Williams D., Hart M., Goswami R., Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?-the routine use of anti-nuclear antibody screening ELISAs. Clinical Laboratory 2007 53 3-4 183 191 2-s2.0-34247548763 (Pubitemid 46656575)
111. Schmitt J., Papisch W., Recombinant autoantigens. Autoimmunity Reviews 2002 1 1-2 79 88 2-s2.0-0041796562 10.1016/S1568-9972(01)00013-1 (Pubitemid 38367430)
112. Schulte-Pelkum J., Fritzler M., Mahler M., Latest update on the Ro/SS-A autoantibody system. Autoimmunity Reviews 2009 8 7 632 637 2-s2.0-67349165090 10.1016/j.autrev.2009.02.010
113. Mahler M., Silverman E. D., Schulte-Pelkum J., Fritzler M. J., Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality? Autoimmunity Reviews 2010 9 11 756 760 2-s2.0-77956188883 10.1016/j.autrev.2010.06.005
114. Mahler M., Sm peptides in differentiation of autoimmune diseases. Advances in Clinical Chemistry 2011 54 109 128 2-s2.0-79953852388 10.1016/B978-0-12-387025-4.00005-4
115. Mahler M., Silverman E. D., Fritzler M. J., Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods. Lupus 2010 19 13 1527 1533 2-s2.0-78649279390 10.1177/0961203310375265
116. Mahler M., Miyachi K., Peebles C., Fritzler M. J., The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmunity Reviews 2012 11 771 775
117. Maes L., Blockmans D., Verschueren P., Westhovens R., Op De Beéck K., Vermeersch P., Van den Bergh K., Burlingame R. W., Mahler M., Bossuyt X., Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma. Clinica Chimica Acta 2010 411 13-14 965 971 2-s2.0-77952552878 10.1016/j.cca.2010.03.018
118. Mahler M., Gascon C., Patel S., Ceribelli A., Fritzler M. J., Swart A., Chan E. K., Satoh M., Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay. Arthritis Research & Therapy 2013 15, article R50
119. Bordet C., Performance of the Inno-Lia Ana test in the detection of the main autoantibodies involved in connective tissue diseases. Annales de Biologie Clinique 2001 59 6 767 768 2-s2.0-18744434492 (Pubitemid 33081373)
120. Lee S. A., Kahng J., Kim Y., Park Y. J., Han K., Kwok S. K., Park S. H., Oh E. J., Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease. Journal of Clinical Laboratory Analysis 2012 26 307 314
121. López-Longo F. J., Rodríguez-Mahou M., Escalona-Monge M., González C. M., Monteagudo I., Carreño-Pérez L., Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus 2003 12 8 623 629 2-s2.0-0042967596 10.1191/0961203303lu439oa (Pubitemid 37021799)
122. Almeida González D., Cabrera de León A., Rodríguez Pérez M. D. C., Brito Díaz B., González Hernández A., García García D., Vázquez Moncholi C., Aguirre Jaime A., Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. Journal of Immunological Methods 2010 360 1-2 89 95 2-s2.0-77955711393 10.1016/j.jim.2010.06.013
123. Shovman O., Gilburd B., Zandman-Goddard G., Yehiely A., Langevitz P., Shoenfeld Y., Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005 38 1 105 109 2-s2.0-17144378568 10.1080/08916930400022707 (Pubitemid 40515010)
124. Hanly J. G., Su L., Farewell V., Fritzler M. J., Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. Journal of Immunological Methods 2010 358 1-2 75 80 2-s2.0-77953291702 10.1016/j.jim.2010.04.005
125. Hanly J. G., Thompson K., McCurdy G., Fougere L., Theriault C., Wilton K., Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. Journal of Immunological Methods 2010 352 1-2 147 152 2-s2.0-71849102119 10.1016/j.jim.2009.10.003
126. Caramaschi P., Ruzzenente O., Pieropan S., Volpe A., Carletto A., Bambara L. M., Biasi D., Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results. Rheumatology International 2007 27 7
127. Copple S. S., Martins T. B., Masterson C., Joly E., Hill H. R., Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Annals of the New York Academy of Sciences 2007 1109 464 472 2-s2.0-34848924372 10.1196/annals.1398.052 (Pubitemid 47511389)
128. Gilburd B., Abu-Shakra M., Shoenfeld Y., Giordano A., Bocci E. B., Delle Monache F., Gerli R., Autoantibodies profile in the sera of patients with sjogren's syndrome: the ANA evaluation-a homogeneous, multiplexed system. Clinical and Developmental Immunology 2004 11 1 53 56 2-s2.0-1842633111 10.1080/10446670410001670490 (Pubitemid 38478564)
129. Nifli A.-P., Notas G., Mamoulaki M., Niniraki M., Ampartzaki V., Theodoropoulos P. A., Kopnitsky M. J., Castanas E., Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. Journal of Immunological Methods 2006 311 1-2 189 197 2-s2.0-33646104678 10.1016/j.jim.2006.02.004
130. Uto K., Hayashi N., Kinoshita S., Kawano S., Kumagai S., Evaluation of simultaneous detection of specific antinuclear antibodies using multiplexed technology. Rinsho Byori 2009 57 10 941 953 2-s2.0-73449088415
131. Fritzler M. J., Behmanesh F., Fritzler M. L., Analysis of human sera that are polyreactive in an addressable laser bead immunoassay. Clinical Immunology 2006 120 3 349 356 2-s2.0-33746837662 10.1016/j.clim.2006.03.007 (Pubitemid 44175894)
132. Bernardini S., Infantino M., Bellincampi L., Nuccetelli M., Afeltra A., Iori R., Biroccio A., Urbani A., Federici G., Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay. Clinical Chemistry and Laboratory Medicine 2004 42 10 1155 1160 2-s2.0-8344221938 10.1515/CCLM.2004.235 (Pubitemid 39481157)
133. Bayer P. M., Bauerfeind S., Bienvenu J., Fabien N., Frei P. C., Gilburd B., Heide K.-G., Hoier-Madsen M., Meroni P. L., Monier J. C., Monneret G., Panzeri P., Shoenfeld Y., Spertini F., Wiik A., Multicenter evaluation study on a new HEP2 ANA screening enzyme immune assay. Journal of Autoimmunity 1999 13 1 89 93 2-s2.0-0032765522 10.1006/jaut.1999.0298 (Pubitemid 29367011)
134. Bayer P. M., Fabian B., Hübl W., Immunofluorescence assays (IFA) and enzyme-linked immunosorbent assays (ELISA) in autoimmune disease diagnostics-technique, benefits, limitations and applications. Scandinavian Journal of Clinical and Laboratory Investigation, Supplement 2001 61 235 68 76 2-s2.0-0034740512 (Pubitemid 33044519)
135. Lehmann H.-P., Block D., Markert-Hahn C., Zolg J. W., New concepts in systemic autoimmunity testing. Scandinavian Journal of Clinical and Laboratory Investigation, Supplement 2001 61 235 84 90 2-s2.0-0034740510 (Pubitemid 33044521)
136. Lehmann H.-P., Fuhling I., Ott C., Hudepohl B., Haass M., HEp2 ANA EIA: a new fully automated assay for the screening of antinuclear antibodies. Israel Medical Association Journal 2000 2 8 646 648 2-s2.0-0033844301
137. Bossuyt X., Evaluation of two automated enzyme immunoassays for detection of antinuclear antibodies. Clinical Chemistry and Laboratory Medicine 2000 38 10 1033 1037 2-s2.0-0033645581
138. Hayashi N., Kawamoto T., Mukai M., Morinobu A., Koshiba M., Kondo S., Maekawa S., Kumagai S., Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clinical Chemistry 2001 47 9 1649 1659 2-s2.0-0034873059 (Pubitemid 32781579)
139. Maguire G. A., Ginawi A., Lee J., Lim A. Y. N., Wood G., Houghton S., Kumararatne D. S., Gaston H. J. S., Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence. Rheumatology 2009 48 8 1013 1014 2-s2.0-70149112566 10.1093/rheumatology/kep137
140. Ghillani P., Rouquette A. M., Desgruelles C., Hauguel N., Le Pendeven C., Piette J. C., Musset L., Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Annals of the New York Academy of Sciences 2007 1109 407 413 2-s2.0-34848856446 10.1196/annals.1398.046 (Pubitemid 47511383)
141. Peterson L. K., Wells D., Shaw L., Velez M.-G., Harbeck R., Dragone L. L., Novel method for quantitative ANA measurement using near-infrared imaging. Journal of Immunological Methods 2009 349 1-2 1 8 2-s2.0-70149114147 10.1016/j.jim.2009.08.010
142. Grossmann K., Roggenbuck D., Schröder C., Conrad K., Schierack P., Sack U., Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay. Cytometry A 2011 79 2 118 125 2-s2.0-79251478029 10.1002/cyto.a.21009
143. Smith J., Onley D., Garey C., Crowther S., Cahir N., Johanson A., Painter S., Harradence G., Davis R., Swarbrick P., Determination of ANA specificity using the UltraPlex ™ platform. Annals of the New York Academy of Sciences 2005 1050 286 294 2-s2.0-23744465290 10.1196/annals.1313.030 (Pubitemid 41129446)
144. Robinson W. H., DiGennaro C., Hueber W., Haab B. B., Kamachi M., Dean E. J., Fournel S., Fong D., Genovese M. C., Neuman De Vegvar H. E., Skriner K., Hirschberg D. L., Morris R. I., Muller S., Pruijn G. J., Van Venrooij W. J., Smolen J. S., Brown P. O., Steinman L., Utz P. J., Autoantigen microarrays for multiplex characterization of autoantibody responses. Nature Medicine 2002 8 3 295 301 2-s2.0-18344385481 10.1038/nm0302-295 (Pubitemid 34250109)
145. Utz P. J., Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 2004 13 5 304 311 2-s2.0-2942754023 10.1191/0961203303lu1017oa (Pubitemid 38788487)
146. Balboni I., Limb C., Tenenbaum J. D., Utz P. J., Evaluation of microarray surfaces and arraying parameters for autoantibody profiling. Proteomics 2008 8 17 3443 3449 2-s2.0-52649112204 10.1002/pmic.200800146
147. González C., García-Berrocal B., Pérez M., Navajo J. A., Herraez O., González-Buitrago J. M., Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clinica Chimica Acta 2005 359 1-2 109 114 2-s2.0-23644443834 10.1016/j.cccn.2005.03.042 (Pubitemid 41116302)
148. Parker J. C., Bunn C. C., Sensitivity of the Phadia EliA connective tissue disease screen for less common disease-specific autoantibodies. Journal of Clinical Pathology 2011 64 7 631 633 2-s2.0-79959339586 10.1136/jcp.2010. 084756
149. Bentow C., Seaman A., Swart A., Shikhman A., Goodman N., and Mahler M., Evaluation of a novel chemiluminescent assay (QUANTA Flash CTD Screen Plus) for the rapid detection of autoantibodies in systemic autoimmune rheumatic diseases. Proceedings of the 11th Dresden Symposium on Autoantibodies 2013 Dresden, Germany
150. Chan E. K. L., Fritzler M. J., Wiik A., Andrade L. E. C., Reeves W. H., Tincani A., Meroni P. L., AutoAbSC.Org-autoantibody standardization committee in 2006. Autoimmunity Reviews 2007 6 8 577 580 2-s2.0-34548510119 10.1016/j.autrev.2007.05.001 (Pubitemid 47374622)
151. Bossuyt X., Louche C., Wiik A., Standardisation in clinical laboratory medicine: an ethical reflection. Annals of the Rheumatic Diseases 2008 67 8 1061 1063 2-s2.0-47949088293 10.1136/ard.2007.084228
152. Fritzler M. J., Wiik A., Tan E. M., Smolen J. S., McDougal J. S., Chan E. K. L., Gordon T. P., Hardin J. A., Kalden J. R., Lahita R. G., Maini R. N., Reeves W. H., Rothfield N. F., Takasaki Y., Wilson M., Byrd M. G., Slivka L., Koziol J. A., A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. Journal of Rheumatology 2003 30 11 2374 2381 2-s2.0-0042348749 (Pubitemid 37413896)
153. Smolen J. S., Butcher B., Fritzler M. J., Gordon T., Hardin J., Kalden J. R., Lahita R., Maini R. N., Reeves W., Reichlin M., Rothfield N., Takasaki Y., Van Venrooij W. J., Tan E. M., Reference sera for antinuclear antibodies: II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. Arthritis & Rheumatism 1997 40 3 413 418 2-s2.0-0030949749 10.1002/art.1780400304 (Pubitemid 27123654)
154. Tan E. M., Smolen J. S., McDougal J. S., A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis & Rheumatology 1999 42 455 464 (Pubitemid 29136093)
155. Tan E. M., Smolen J. S., McDougal J. S., Fritzler M. J., Gordon T., Hardin J. A., Kalden J. R., Lahita R. G., Maini R. N., Reeves W. H., Rothfield N. F., Takasaki Y., Wiik A., Wilson M., Koziol J. A., A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. Journal of Rheumatology 2002 29 1 68 74 2-s2.0-0036137708 (Pubitemid 34041861)
156. James K., Carpenter A. B., Cook L., Marchand R., Nakamura R. M., Development of the antinuclear and anticytoplasmic antibody consensus panel by the Association of Medical Laboratory Immunologists. Clinical and Diagnostic Laboratory Immunology 2000 7 3 436 443 2-s2.0-0034026575 10.1128/CDLI.7.3.436- 443.2000 (Pubitemid 30263037)
157. Mahler M., Fritzler M. J., Blüthner M., Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Research & Therapy 2005 7 1 R19 R29 2-s2.0-12544255536
158. Feltkamp T. E. W., Standards for ANA and anti-DNA. Clinical Rheumatology 1990 9 1 74 81 2-s2.0-0025011960 (Pubitemid 20338108)
159. Damoiseaux J., Tervaert J. W. C., Derksen R., Hamann D., Hooijkaas H., Klasen I., Kallenberg C., Limburg P., Smeenk R., Autoantibody standardization in the Netherlands: the past, the present, and the future. Annals of the New York Academy of Sciences 2009 1173 10 14 2-s2.0-69949172408 10.1111/j.1749-6632.2009. 04631.x
160. Sack U., Conrad K., Csernok E., Frank I., Haass M., Krieger T., Seyfarth M., Schlosser U., Schmidt R. E., Witte T., Standardization of autoimmune diagnostics in Germany: activities of the German group in the European autoimmune standardization initiative. Annals of the New York Academy of Sciences 2007 1109 31 36 2-s2.0-34848890985 10.1196/annals.1398.004 (Pubitemid 47511341)
161. Meroni P. L., Biggioggero M., Pierangeli S. S., Sheldon J., Zegers I., Borghi M. O., Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nature Reviews Rheumatology 2014 10 35 43 10.1038/nrrheum.2013.180